# Trial of Hypofractionated Radiation Therapy for Glioblastoma

> **NCT02206230** · PHASE2 · COMPLETED · sponsor: **AHS Cancer Control Alberta** · enrollment: 133 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **RADIATION:** Hypofractionated radiation therapy
- **RADIATION:** Standard radiation therapy

## Key facts

- **NCT ID:** NCT02206230
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-25
- **Primary completion:** 2023-02-14
- **Final completion:** 2023-02-14
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2024-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02206230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02206230, "Trial of Hypofractionated Radiation Therapy for Glioblastoma". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT02206230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*